Kabra Extrusion Technik Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
KABRAEXTRU · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Extrusion Technik has submitted its quarterly Reg. 32 compliance filing for the quarter ended 30 June 2025, confirming that there is NIL deviation or variation in the use of proceeds from its preferential issues and warrant conversions. The company raised a total of approximately Rs. 101.02 crore across five tranches between February 2022 and August 2023 (through allotments and warrant-to-equity conversions). Out of this, Rs. 100.90 crore has been utilized as of 30 June 2025, against the original stated objects of funding R&D activities, operating expenditure, and other Board-approved purposes. No monitoring agency was applicable for these issues, and the Audit Committee has reported NIL comments after review, indicating clean compliance with the originally disclosed use of funds.
This is a routine regulatory compliance filing with no material impact on shareholders — it simply confirms that the company has used the money raised from preferential issues in line with what was originally communicated. No red flags for investors; reinforces governance and disclosure quality.